Top Stocks
Dividend Investing
ETFs
Stock Comparison
About Us
Working with TipRanks
Follow Us
Imago BioSciences (IMGO)
NASDAQ:IMGO
Imago BioSciences (IMGO) Stock Price & Analysis
0 Followers
IMGO Stock Chart & Stats
Day’s Range― - ―
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)N/A
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding33,841,229
10 Day Avg. Volume0
30 Day Avg. Volume244,029
Standard Deviation0.33
R-Squared0.28
Alpha0.09
Financial Highlights & Ratios
Price to Book (P/B)7.06
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio-31.20
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Imago BioSciences News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
Product Monthly Users
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
IMGO FAQ
What was Imago BioSciences’s price range in the past 12 months?
Currently, no data Available
What is Imago BioSciences’s market cap?
Currently, no data Available
When is Imago BioSciences’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Imago BioSciences’s earnings last quarter?
Currently, no data Available
Is Imago BioSciences overvalued?
According to Wall Street analysts Imago BioSciences’s price is currently same.
Does Imago BioSciences pay dividends?
Imago BioSciences does not currently pay dividends.
What is Imago BioSciences’s EPS estimate?
Imago BioSciences’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Imago BioSciences have?
Currently, no data Available
What happened to Imago BioSciences’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Imago BioSciences?
Among the largest hedge funds holding Imago BioSciences’s share is Omega Fund Management, LLC. It holds Imago BioSciences’s shares valued at 109M.
---
Imago BioSciences Stock Smart Score
Learn more about TipRanks Smart Score
Company Description
Imago BioSciences
Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. It is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (ET) and myelofibrosis (MF).
---
Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.
Keros Therapeutics
―
BridgeBio Pharma
―
Inhibrx
―
Travere Therapeutics
―
Chinook Therapeutics
―
---